239 related articles for article (PubMed ID: 509955)
21. Interception by post-coital IUD insertion.
Van Santen MR; Haspels AA
Contracept Deliv Syst; 1981 Jul; 2(3):189-200. PubMed ID: 12278905
[TBL] [Abstract][Full Text] [Related]
22. The safety of intrauterine devices among young women: a systematic review.
Jatlaoui TC; Riley HEM; Curtis KM
Contraception; 2017 Jan; 95(1):17-39. PubMed ID: 27771475
[TBL] [Abstract][Full Text] [Related]
23. Prolonged intrauterine contraception: a seven-year randomized study of the levonorgestrel 20 mcg/day (LNg 20) and the Copper T380 Ag IUDS.
Sivin I; Stern J; Coutinho E; Mattos CE; el Mahgoub S; Diaz S; Pavez M; Alvarez F; Brache V; Thevenin F
Contraception; 1991 Nov; 44(5):473-80. PubMed ID: 1797462
[TBL] [Abstract][Full Text] [Related]
24. Performances of copper T 380A and multiload copper 375/250 intrauterine contraceptive devices in a comparative clinical trial.
Arowojolu AO; Otolorin EO; Ladipo OA
Afr J Med Med Sci; 1995 Mar; 24(1):59-65. PubMed ID: 7495202
[TBL] [Abstract][Full Text] [Related]
25. A review of the association between intrauterine devices and acute pelvic inflammatory disease.
Ory HW
J Reprod Med; 1978 Apr; 20(4):200-4. PubMed ID: 353272
[TBL] [Abstract][Full Text] [Related]
26. Today's IUDs offer safe, effective contraception.
Finger WR
Netw Res Triangle Park N C; 1993 Mar; 13(3):12-5. PubMed ID: 12318094
[TBL] [Abstract][Full Text] [Related]
27. IUDs and PID: understanding the American situation.
Netw Res Triangle Park N C; 1987; 8(2):8. PubMed ID: 12268660
[TBL] [Abstract][Full Text] [Related]
28. Epidemiology of pelvic inflammatory disease in parous women with special reference to intrauterine device use.
Buchan H; Villard-Mackintosh L; Vessey M; Yeates D; McPherson K
Br J Obstet Gynaecol; 1990 Sep; 97(9):780-8. PubMed ID: 2242362
[TBL] [Abstract][Full Text] [Related]
29. Reconsidering IUDs.
Goldberg B
AVSC News; 1992 Jul; 30(2):7-8. PubMed ID: 12285571
[TBL] [Abstract][Full Text] [Related]
30. Fertility following ectopic pregnancy with special reference to previous use of an intra-uterine contraceptive device (IUCD).
Sandvei R; Ulstein M; Wollen AL
Acta Obstet Gynecol Scand; 1987; 66(2):131-5. PubMed ID: 3618137
[TBL] [Abstract][Full Text] [Related]
31. The intrauterine device, pelvic inflammatory disease, and infertility: the confusion between hypothesis and knowledge.
Grimes DA
Fertil Steril; 1992 Oct; 58(4):670-3. PubMed ID: 1426307
[TBL] [Abstract][Full Text] [Related]
32. Pathogenesis of acute pelvic inflammatory disease: role of contraception and other risk factors.
Eschenbach DA; Harnisch JP; Holmes KK
Am J Obstet Gynecol; 1977 Aug; 128(8):838-50. PubMed ID: 407795
[TBL] [Abstract][Full Text] [Related]
33. Appropriate follow up to detect potential adverse events after initiation of select contraceptive methods: a systematic review.
Steenland MW; Zapata LB; Brahmi D; Marchbanks PA; Curtis KM
Contraception; 2013 May; 87(5):611-24. PubMed ID: 23177264
[TBL] [Abstract][Full Text] [Related]
34. A prospective New Zealand study of fertility after removal of copper intrauterine contraceptive devices for conception and because of complications: a four-year study.
Wilson JC
Am J Obstet Gynecol; 1989 Feb; 160(2):391-6. PubMed ID: 2916624
[TBL] [Abstract][Full Text] [Related]
35. Was the Dalkon Shield a safe and effective intrauterine device? The conflict between case-control and clinical trial study findings.
Mumford SD; Kessel E
Fertil Steril; 1992 Jun; 57(6):1151-76. PubMed ID: 1601137
[TBL] [Abstract][Full Text] [Related]
36. Modern intra-uterine devices.
Odlind V
Baillieres Clin Obstet Gynaecol; 1996 Apr; 10(1):55-67. PubMed ID: 8736722
[TBL] [Abstract][Full Text] [Related]
37. Experience with the copper 7 intrauterine device in an adolescent population.
Kulig JW; Rauh JL; Burket RL; Cabot HM; Brookman RR
J Pediatr; 1980 Apr; 96(4):746-50. PubMed ID: 7359288
[TBL] [Abstract][Full Text] [Related]
38. The intrauterine device in the present and future.
Rivera R; Chi IC; Farr G
Curr Opin Obstet Gynecol; 1993 Dec; 5(6):829-32. PubMed ID: 8286697
[TBL] [Abstract][Full Text] [Related]
39. Intrauterine devices and pelvic inflammatory disease: recent developments.
Grimes DA
Contraception; 1987 Jul; 36(1):97-109. PubMed ID: 3311628
[TBL] [Abstract][Full Text] [Related]
40. [Copper-7 intrauterine device (Gravigard). Report of experience].
Jürgensen O; Stenzel I; Wirth A; Sina D; Taubert HD
Fortschr Med; 1976 Mar; 94(9):515-21. PubMed ID: 964914
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
